Industry Experts

Kerstin Hofer is Science & People Lead at Roche Pharma Research and Early Development, where she leads the bioconjugation lab. She has extensive experience in the delivery of oligonucleotide-based therapeutics to target tissues, such as the brain. Prior to joining Roche, Kerstin completed her BSc and MSc degrees in Chemistry and biochemistry at the University of Munich and her DPhil in Chemical Biology at the University of Oxford.